» Authors » I Buno

I Buno

Explore the profile of I Buno including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 242
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Laperche C, Sanz-Villanueva L, Diaz Crespo F, Muniz P, Martin Rojas R, Carbonell D, et al.
BMC Cancer . 2022 Nov; 22(1):1224. PMID: 36443715
No abstract available.
2.
Martinez-Laperche C, Sanz-Villanueva L, Diaz Crespo F, Muniz P, Martin Rojas R, Carbonell D, et al.
BMC Cancer . 2022 Sep; 22(1):982. PMID: 36104682
EZH2 is mutated in nearly 25% of follicular lymphoma (FL) cases. Little is known about how EZH2 affects patients' response to therapy. In this context, the aim of this study...
3.
Kwon M, Bautista G, Balsalobre P, Sanchez-Ortega I, Montesinos P, Bermudez A, et al.
Bone Marrow Transplant . 2017 Mar; 52(8):1138-1143. PMID: 28346415
For patients with AML, the best alternative donor remains to be defined. We analyze outcomes of patients who underwent myeloablative umbilical cord blood or haploidentical hemopoietic stem cell transplantation (HSCT)...
4.
Gayoso J, Balsalobre P, Pascual M, Castilla-Llorente C, Lopez-Corral L, Kwon M, et al.
Bone Marrow Transplant . 2016 May; 51(10):1307-1312. PMID: 27159177
Relapsed or refractory Hodgkin lymphoma (advanced HL) still remains a therapeutic challenge. Recently, unmanipulated haploidentical related donor transplant with reduced conditioning regimen (HAPLO-RIC) and post-transplant cyclophosphamide (PT-Cy) as GvHD prophylaxis...
5.
Martinez-Moreno M, Leiva M, Aguilera-Montilla N, Sevilla-Movilla S, Isern de Val S, Arellano-Sanchez N, et al.
Leukemia . 2015 Dec; 30(4):861-72. PMID: 26658839
Multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) cells must attach to the bone marrow (BM) microvasculature before lodging in the BM microenvironment. Using intravital microscopy (IVM) of the BM...
6.
Santos N, Rodriguez-Romanos R, Nieto J, Buno I, Vallejo C, Jimenez-Velasco A, et al.
Bone Marrow Transplant . 2015 Sep; 51(1):79-82. PMID: 26367234
Minor histocompatibility Ags (mHags) have been implicated in the pathogenesis of GVHD after allogeneic hematopoietic stem cell transplantation (HSCT). Uridine diphospho-glucuronosyltransferase 2B17 (UGT2B17) gene deletion may act as a mHag...
7.
Olmedo C, Pla R, Bellon J, Bardinet T, Buno I, Banares R
Rev Calid Asist . 2015 Jul; 30(5):265-72. PMID: 26123577
Objective: A Health Research Institute is a powerful strategic commitment to promote biomedical research in hospitals. To assess user satisfaction is an essential quality requirement. The aim of this study...
8.
Bosch-Vizcaya A, Rodriguez-Romanos R, Nieto J, de la Camara R, Brunet S, Vallejo C, et al.
Bone Marrow Transplant . 2014 Oct; 50(2):298-300. PMID: 25330223
No abstract available.
9.
Kwon M, Martinez-Laperche C, Balsalobre P, Serrano D, Anguita J, Gayoso J, et al.
Bone Marrow Transplant . 2013 Nov; 49(2):212-8. PMID: 24212562
Single-unit umbilical cord blood (CB) SCT is limited by low total nucleated cell (TNC) dose. Co-infusion of CD34+ cells from a third party HLA-mismatched donor, known as dual or haplo-cord...
10.
Menezes J, Acquadro F, Wiseman M, Gomez-Lopez G, Salgado R, Talavera-Casanas J, et al.
Leukemia . 2013 Sep; 28(4):823-9. PMID: 24072100
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very rare disease that currently lacks genomic and genetic biomarkers to assist in its clinical management. We performed whole-exome sequencing (WES) of...